Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 1, 2016, Pages 128-134

  Rezaei Sadabady, Rogaie ^a   Eidi, Akram ^a   Zarghami, Nosratollah ^b   Barzegar, Abolfazl ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Anti cancer activity; Antioxidant; Liposome; Nanoparticles; Quercetin

Indexed keywords

ANTIOXIDANTS; BIOCHEMISTRY; CELLS; CYTOLOGY; DISEASES; DRUG DELIVERY; FREE RADICALS; FRUITS; IRON RESEARCH; LIPOSOMES; NANOPARTICLES; PHENOLS; SOLUBILITY; TUMORS;

ANTI-OXIDANT ACTIVITIES; ANTICANCER ACTIVITIES; EQUIMOLAR CONCENTRATIONS; FREE RADICAL SCAVENGING ACTIVITY; LIPOSOMAL DELIVERY SYSTEM; NATURAL BIOFLAVONOIDS; PHARMACEUTICAL APPLICATIONS; QUERCETIN;

FLAVONOIDS;

CUMENE HYDROPEROXIDE; FERRIC ION; LIPOSOME; QUERCETIN; REACTIVE OXYGEN METABOLITE; 1,1-DIPHENYL-2-PICRYLHYDRAZYL; BENZENE DERIVATIVE; BIPHENYL DERIVATIVE; FREE RADICAL; IRON; PICRIC ACID; SCAVENGER;

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CELL PROTECTION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG SOLUBILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIPOSOMAL DELIVERY; MCF 7 CELL LINE; NANOENCAPSULATION; NANOPHARMACEUTICS; ZETA POTENTIAL; ANTAGONISTS AND INHIBITORS; BIOAVAILABILITY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MCF-7 CELL LINE; OXIDATION REDUCTION REACTION; SOLUBILITY; SYNTHESIS;

BENZENE DERIVATIVES; BIOLOGICAL AVAILABILITY; BIPHENYL COMPOUNDS; CELL SURVIVAL; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; IRON; LIPOSOMES; MCF-7 CELLS; OXIDATION-REDUCTION; PICRATES; QUERCETIN; SOLUBILITY;

EID: 84971607492     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.926456     Document Type: Article

References (36)

1. Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K. 2014. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. Epub Ahead of Print.
2. Akbarzadeh A, Mikaeili H, Asgari D, Zarghami N, Mohammad R, Davaran S. 2012a. Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7: 511-526.
3. Akbarzadeh A, Mohamad S, Davaran S. 2012d. Magnetic nanoparticles: preparation, physical properties and applications in biomedicine. Nanoscale Res Lett. 7: 144-157.
4. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8: 102.
5. Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012c. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol. 10: 46-58.
6. Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012b. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ. 5: 13-25.
7. Angelini G, Boncompagni S, De Maria P, De Nardi M, Fontana A, Gasbarri C, Menna E. 2007. Layer-by-layer deposition of shortened nanotubes or polyethylene glycol-derivatized nanotubes on liposomes: A tool for increasing liposome stability. Carbon. 45: 2479-2485.
8. Barenholz Y. 2001. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci. 6: 66-77.
9. Batist G, Ramakrishnan G, Rao CS, Chandrasekharan A, Gutheil J, Guthrie T, et al. 2001. Reducedcardiotoxicity and preserved antitumor efficacy ofliposome-encapsulated doxorubicin and cyclophosphamidecompared with conventional doxorubicinand cyclophosphamide in a randomized, multicentertrial of metastatic breast cancer. J Clin Oncol. 19: 1444-1454.
10. Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Ghamari MF, Soghrati MM, et al. 2013. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release. JEAS. 3: 108-115.
11. Davaran S, Alimirzalu S, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A, Khandaghi AA, et al. 2014a. Physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(Nisopropylacrylamide) for anti-cancer drugs delivery. Asian Pac J Cancer Prev. 15: 49-54.
12. Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A. 2014b. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide-β-cyclodextrin copolymer nanoparticles containing albumin. Adv Nanoparticles. 3: 14-22.
13. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh S, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. BioImpacts. 3: 67-74.
14. Erkoc F, Erkoc S. 2002. Theoretical investigation of flavonoids naringenin and genistein. Theochem. 583: 163-167.
15. Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, et al. 2013. Study of inhibitory effect of β-cyclodextrin-helenalin complex on HTERT gene expression in T47D breast cancer cell line by real time quantitative PCR (q-PCR). Asian Pac J Cancer Prev. 14: 6949-6953.
16. He X, Liu RH. 2008. Phytochemicals of apple peels: isolation, structure elucidation, and their antiproliferative and antioxidant activities. J Agric Food Chem. 56: 9905-9910.
17. Klein E, Matis M, Lukes V, Cibulkova Z. 2006. The applicability of AM1and PM3semi-empirical methods for the study of N-H bond dissociation enthalpies and ionization potential of amine type antioxidants. Polym Degrad Stab. 91: 262-270.
18. Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical quantum dot. Nanoscale Res Lett. 9: 131-136.
19. Kaul G, Amiji M. 2002. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res. 19: 1061-1067.
20. Lee SE, Hwang HJ, Ha JS, Jeong HS, Kim JH. 2003. Screening of medicinal plant extracts for antioxidant activity. Life Science 73: 167-117.
21. Lefer DJ, Granger DN. 2000. Oxidative stress and cardiac disease. Am J Med. 109: 315-323.
22. Lian T, Ho RJ. 2001. Trends and developments in liposome drug delivery systems. J Pharm Sci. 90: 667-680.
23. Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, Joo SW. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin-curcumin combination. Asian Pac J Cancer Prev. 14: 6595-6599.
24. Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM. 2006. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med. 40: 341-347.
25. Phromnoi K, Yodkeeree S, Anuchapreeda S, Limtraku P. 2009. Inhibition of MMP-3 activity and invasion of the MDAMB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol Sin. 30: 1169-1176.
26. Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8: 485.
27. Rezaei-Sadabady R, Zarghami N, Barzegar A, Eidi A, Akbarzadeh A, Rezaei-Tavirani M. 2013. Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft. 2: 13-18.
28. Sahoo SK, Labhasetwar V. 2003. Nanotech approaches to drug delivery and imaging. Drug Discov Today. 15: 1112-1120.
29. Sharma A, Sharma US. 1997. Liposomes in drug delivery: progress and limitations. Int J Pharm. 154: 123-140.
30. Stone WL, Mukherjee S, Smith M, Das SK. 2002. Therapeutic uses of antioxidant liposomes. Methods Mol Biol. 199: 145-161.
31. Stone WL, Smith M. 2004. Therapeutic uses of antioxidant liposomes. Mol Biotechnol. 27: 217-230
32. Tabatabaei Mirakabad FS, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S. 2014. PLGA-cased nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15: 517-535.
33. Torchilin VP 2005. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 4: 145-160.
34. Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 7: 276.
35. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. 1995. Vascular permeabilityin a human tumor xenograft: molecular sizedependence and cutoff size. Cancer Res. 55: 3752-3756.
36. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. 2008. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 83: 761-769.